TFFP: The Tip Of The Iceberg
August 14, 2020
TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION therapeutics for its Thin Film Freezing Technology in Combination with niclosamide
August 13, 2020
July Recap, August Preview...Best Month Yet at Tailwinds
August 1, 2020
TFFP Applies Thin Film Freezing to Remdesivir with Outstanding Results
July 28, 2020
MONAKER GROUP ENTERS INTO AGREEMENT TO ACQUIRE TECHNOLOGY LEADER HOTPLAY AND 33% INTEREST IN AXION VENTURES, INC.
July 23, 2020
This Week at Tailwinds
July 18, 2020
INMB's XPro1595...A Potential Disease Modifying Therapy for Alzheimer's
July 16, 2020
INmune Bio, Inc. Announces Interim Phase Ib Data Demonstrating That XPro1595 Decreases Neuroinflammation in Patients with Alzheimer’s Disease
July 13, 2020
Previewing the 2nd Half of 2020...and Other Updates From The Week
July 11, 2020
Catasys Announces National Rollout…Here’s What’s Next
July 1, 2020
All our articles are free for everyone to enjoy, however you must register as a user. Please take the time to sign up, it’s free and we do not share your information with anyone.
For those interested in receiving alerts when we buy or sell stocks for our managed accounts, you should consider becoming a premium subscriber. A premium subscription costs $250 per year and subscribers get emails about every transaction taken in our portfolios, including names that have yet to be added to the Tailwinds site.
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.